Gary D. Kao, MD, PhD

faculty photo
Associate Professor of Radiation Oncology
Department: Radiation Oncology
Graduate Group Affiliations

Contact information
Department of Radiation Oncology
Smilow Center for Translational Research, Room 8-134
3400 Civic Center Blvd.
University of Pennsylvania
Philadelphia, PA 19104
Office: 215-573-2285
Education:
BA (Philosophy)
Johns Hopkins University , 1984.
M.D. (Medicine)
Johns Hopkins School of Medicine, 1988.
PhD (Molecular Biology)
University of Pennsylvania, 1998.
Permanent link
 

Description of Research Expertise

Molecular and Cellular Biology

Selected Publications

Kimple RJ, Kao GD: A 10-year analysis of american society for radiation oncology junior faculty career development awards. Int J Radiat Oncol Biol Phys. 85(4): 924-8, Mar 2013.

Baumann Brian C, Kao Gary D, Mahmud Abdullah, Harada Takamasa, Swift Joe, Chapman Christina, Xu Xiangsheng, Discher Dennis E, Dorsey Jay F: Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy. Oncotarget. 4(1): 64-79, Dec 23 2012.

Baumann BC, Dorsey JF, Benci JL, Joh DY, Kao GD: Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. J Vis Exp.(67), Sep 25 2012.

Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, Kao GD, Dorsey JF: An integrated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain tumors using the small animal radiation research platform. Transl Oncol. 5(4): 230-7, Aug 2012.

Smith JA, Yeung J, Kao GD, Daniel R: A role for the histone deacetylase HDAC4 in the life-cycle of HIV-1-based vectors. Virol J. 7: 237, Sep 16 2010.

Dorsey JF, Dowling ML, Kim M, Voong R, Solin LJ, Kao GD: Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions. Cancer Biol Ther. 9(10): 809-18, May 15 2010.

Yee SS, Dutta PR, Solin LJ, Vapiwala N, Kao GD: Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy. J Support Oncol. 8(1): 28-34, Jan-Feb 2010.

Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells. Mol Cancer Ther. 8(12): 3285-95, Dec 2009.

Crisanti MC, Wallace AF, Kapoor V, Vandermeers F, Dowling ML, Pereira LP, Coleman K, Campling BG, Fridlender ZG, Kao GD, Albelda SM: The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer. Mol Cancer Ther. 8(8): 2221-31, Aug 2009.

Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM: HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell. 19(10): 4062-75, Oct 2008.

back to top
Last updated: 04/17/2013
The Trustees of the University of Pennsylvania